Massachusetts Department of Transportation Selects Draganfly for Drone Medical Delivery Demonstration and Reports Its Successful Completion
Draganfly (NASDAQ: DPRO) has successfully completed a medical supply delivery demonstration project for the Massachusetts Department of Transportation (MassDOT) Aeronautics Division. The demonstration, conducted between August and October 2024, simulated the delivery of medical supplies for home-based healthcare support.
Draganfly was one of three companies selected for this innovative pilot project, which aims to explore drone technology for healthcare and emergency management applications. Transportation Secretary Monica Tibbits-Nutt highlighted that drones have already proven valuable for various operations, including MBTA track corridor inspections, highway bridge inspections, and overhead project evaluations.
Draganfly (NASDAQ: DPRO) ha completato con successo un progetto dimostrativo di consegna di forniture mediche per il Dipartimento dei Trasporti del Massachusetts (MassDOT) Divisione Aeronautica. La dimostrazione, condotta tra agosto e ottobre 2024, ha simulato la consegna di forniture mediche per il supporto sanitario a domicilio.
Draganfly è stata una delle tre aziende selezionate per questo innovativo progetto pilota, che mira a esplorare la tecnologia dei droni per applicazioni nel settore sanitario e nella gestione delle emergenze. La Segretaria ai Trasporti Monica Tibbits-Nutt ha sottolineato che i droni si sono già dimostrati preziosi per varie operazioni, tra cui ispezioni dei corridoi ferroviari MBTA, ispezioni dei ponti autostradali e valutazioni di progetti aerei.
Draganfly (NASDAQ: DPRO) ha completado con éxito un proyecto demostrativo de entrega de suministros médicos para el Departamento de Transporte de Massachusetts (MassDOT) División de Aeronáutica. La demostración, realizada entre agosto y octubre de 2024, simuló la entrega de suministros médicos para el apoyo de atención médica domiciliaria.
Draganfly fue una de las tres empresas seleccionadas para este innovador proyecto piloto, que tiene como objetivo explorar la tecnología de drones para aplicaciones en el cuidado de la salud y la gestión de emergencias. La Secretaria de Transporte Monica Tibbits-Nutt destacó que los drones ya han demostrado ser valiosos para diversas operaciones, incluidas las inspecciones de los corredores de vías del MBTA, las inspecciones de puentes en las autopistas y las evaluaciones de proyectos aéreos.
드라간플라이 (NASDAQ: DPRO)는 매사추세츠 교통부 (MassDOT) 항공학 부서를 위한 의료 공급품 배송 시연 프로젝트를 성공적으로 완료했습니다. 이 시연은 2024년 8월부터 10월 사이에 진행되었으며, 가정 기반 의료 지원을 위한 의료 공급품 배송을 시뮬레이션했습니다.
드라간플라이는 이 혁신적인 파일럿 프로젝트에 선정된 세 개 회사 중 하나로, 의료 및 비상 관리 응용 프로그램을 위한 드론 기술을 탐색하는 것을 목표로 하고 있습니다. 교통부 장관 모니카 티빗스-낫은 드론이 이미 MBTA 트랙 회랑 검사, 고속도로 교량 검사 및 공중 프로젝트 평가를 포함한 다양한 작업에 유용하다는 것을 입증했다고 강조했습니다.
Draganfly (NASDAQ: DPRO) a réussi à achever un projet de démonstration de livraison de fournitures médicales pour le Département des Transports du Massachusetts (MassDOT) Division de l'Aéronautique. La démonstration, réalisée entre août et octobre 2024, a simulé la livraison de fournitures médicales pour le soutien aux soins de santé à domicile.
Draganfly était l'une des trois entreprises sélectionnées pour ce projet pilote innovant, qui vise à explorer la technologie des drones pour des applications dans le domaine de la santé et de la gestion des urgences. La secrétaire aux Transports, Monica Tibbits-Nutt, a souligné que les drones ont déjà prouvé leur valeur pour diverses opérations, y compris les inspections des corridors de voies du MBTA, les inspections de ponts autoroutiers et les évaluations de projets aériens.
Draganfly (NASDAQ: DPRO) hat erfolgreich ein Demonstrationsprojekt zur Lieferung von medizinischen Versorgungsgegenständen für die Massachusetts Department of Transportation (MassDOT) Luftfahrtabteilung abgeschlossen. Die Demonstration, die zwischen August und Oktober 2024 durchgeführt wurde, simulierte die Lieferung von medizinischen Versorgungsgegenständen zur Unterstützung der häuslichen Gesundheitsversorgung.
Draganfly war eines von drei Unternehmen, die für dieses innovative Pilotprojekt ausgewählt wurden, das darauf abzielt, die Drohnentechnologie für Anwendungen im Gesundheitswesen und im Notfallmanagement zu erkunden. Verkehrsministerin Monica Tibbits-Nutt hob hervor, dass Drohnen sich bereits für verschiedene Operationen als wertvoll erwiesen haben, einschließlich der Inspektionen von MBTA-Gleiskorridoren, der Inspektionen von Autobahnbrücken und der Evaluierung von Luftprojekten.
- Selected as one of three companies for MassDOT's medical delivery pilot program
- Successfully completed demonstration for medical supply delivery
- Expands into government healthcare logistics sector
- Demonstration was only simulated, not actual medical deliveries
- No immediate revenue impact mentioned from the pilot program
Insights
Draganfly's successful completion of the Massachusetts Department of Transportation's drone medical delivery demonstration represents a strategic positioning win in the growing healthcare logistics market. Being selected as one of only three companies for this demonstration validates Draganfly's technological capabilities in a competitive landscape.
The demonstration focused specifically on simulated delivery of medical supplies for home-based healthcare, addressing a growing need as care delivery increasingly shifts toward home settings. For Draganfly, with its relatively small market capitalization of
This project aligns with broader government trends of exploring drone applications beyond current uses in infrastructure inspection. As noted by MassDOT officials, drones have already proven valuable for track corridor inspections, bridge inspections, and project evaluations.
From a competitive standpoint, this demonstration enhances Draganfly's credibility specifically in the healthcare delivery segment. While the demonstration itself doesn't generate immediate revenue, it positions the company as a potential partner for future state transportation contracts and could serve as a reference case for other jurisdictions.
The demonstration's successful completion indicates Draganfly's technology met the operational requirements for simulated medical deliveries, potentially opening doors to healthcare logistics applications where timely delivery is critical. However, investors should note that the path from successful demonstration to revenue-generating contracts often involves additional procurement processes and regulatory considerations.
Boston, MA., March 18, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is excited to announce it was selected by Massachusetts Department of Transportation (MassDOT) Aeronautics Division for and, successfully completed a demonstration for the simulated delivery of medical supplies for use in support of home-based healthcare.
The medical delivery demonstrations took place between August and October 2024 and involved three selected companies, including Draganfly.
“This medical delivery demonstration underscores the value of drones for many operational needs,” said Transportation Secretary and CEO Monica Tibbits-Nutt, “Drones already have proven useful with operations, including MBTA track corridor inspections, MassDOT Highway bridge inspections, overhead project evaluations, and other needs. We continue to assess the use of drones for other purposes in the future.”
“This demonstration project underscores our commitment to exploring the use of drones to meet critical needs, such as the timely and cost-effective delivery of supplies and devices for healthcare and emergency management, across the Commonwealth,” said MassDOT Aeronautics Acting Administrator Denise Garcia.
“We are grateful to have been selected for this groundbreaking pilot project,” said Cameron Chell, President and CEO of Draganfly. “Our drone technology has the potential to revolutionize the delivery of medical supplies, providing timely and cost-effective solutions for home-based healthcare and emergency responses. This collaboration with MassDOT Aeronautics underscores our credibility and commitment to advancing public safety and healthcare through innovative drone solutions.”
Draganfly’s participation in the Drone Medical Delivery Pilot is a testament to its capabilities, reputation and dedication to providing drone solutions that define industry standards, empowering global organizations, to save time, money, and lives.
About Draganfly
Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) is the creator of quality, cutting-edge drone solutions, software, and AI systems that revolutionize how organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 24 years, Draganfly is an award-winning industry leader serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
For more information on Draganfly, please visit us at www.draganfly.com.
For additional investor information, visit
Media Contact
email: media@draganfly.com
Company Contact
Email: info@draganfly.com
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect to the project’s ability to revolutionize the delivery of medical supplies, providing timely and cost-effective solutions for home-based healthcare and emergency responses. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the COVID-19 pandemic, on the Company’s business, operations and financial condition; the successful integration of technology; the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates; the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions; and liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at www.sedar.com and with the United States Securities and Exchange Commission (the “SEC”) on EDGAR through the SEC’s website at www.sec.gov. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
